Clinical Trial

Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery

Study acronym: MAGNOLIA
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Assess the sensitivity of real-time near-infrared fluorescence imaging to detect microscopic residual disease in the operating room after a complete macroscopic surgical resection of head and neck cancers
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-04-08; most recent amendment 2025-11-24.
Trial Details
NCT Number NCT04842162
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Conditions Head and Neck Cancer
Enrollment 65 participants
Start Date 2020-12-15
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-11-26